Back to Results
First PageMeta Content
Neurotransmitters / Solute carrier family / Membrane biology / Dopamine agonists / Dopamine / Vesicular monoamine transporter 2 / Substantia nigra / Vesicular monoamine transporter / Amphetamine / Biology / Biochemistry / Neurotransmitter transporters


Open Document

Share Result on Facebook

City

Cincinnati / /

Company

A12 / A14 / /

Currency

pence / USD / /

Facility

C terminus / N terminus / University of Cincinnati Medical Center / /

IndustryTerm

transcriptional start site / energy costs / in vivo imaging / inactive products / energy requirements / treatment of Parkinson’s disease / diclofensin increasing media dopamine levels / energy-dependent uptake process / hypothalamo-pituitary dopaminergic systems / dopaminergic systems / mesocortical neuronal systems / ectopic site / messenger systems / hypothalamic dopaminergic systems / therapeutic applications / conditioned media / well-defined dopaminergic systems / /

MedicalCondition

pituitary prolactinomas D. Treatment / schizophrenia / hyperprolactinemia and reproductive disturbances / neurological disorders / prolactinomas / dysfunction / zona / chronic exposure / humans B. Drug-induced PRL release C. Hyperprolactinemia / zona incerta / psychoses / dopamine deficiency / Parkinson’s disease / chronic stress / diseases / deficiency / PRL Inhibitor Dysfunction / disorders / dissociation / Hyperprolactinemia / /

Organization

University of Cincinnati / National Science Foundation / Inhibitor NIRA BEN-JONATHAN AND ROBERT HNASKO Department of Cell Biology / Neurobiology / and Anatomy / Cincinnati Medical Center / /

Person

Gq / ROBERT HNASKO / /

Position

messenger / /

Product

reserpine / haloperidol / epinephrine / soma / glycine / /

ProvinceOrState

TH / Ohio / Alabama / New Foundland and Labrador / PRL / /

Technology

hybridization / gene expression / directed mutagenesis / cloning / DNA binding / /

SocialTag